Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Morabito

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
The Lancet. Oncology|October 14, 2003
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?Giampietro Gasparini, Raffaele Longo, Roberta Sarmiento, et al.
Cancer Journal (Sudbury, Mass.)|August 2, 2005
Thalidomide is inactive in heavily pretreated patients with metastatic breast cancerAlessandro Morabito, Guido Carillio, Raffaele Longo, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Giuseppe Pompilio, Alessandro Morabito, Diego L Cortinovis, et al.
Nature Communications|March 27, 2025
Fatigue damage reduction in hydropower startups with machine learningTill Muser, Ekaterina Krymova, Alessandro Morabito, et al.
Cancers|April 30, 2021
Promising Role of Circulating Tumor Cells in the Management of SCLCAntonella De Luca, Marianna Gallo, Claudia Esposito, et al.
Cancers|July 27, 2024
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future ChallengesDiego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 3, 2005
A complete atrioventricular block secondary to myocardial metastases of lung cancer. A case reportDavid Mocini, Raffaele Longo, Furio Colivicchi, et al.
The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.
Critical Reviews in Oncology/Hematology|December 13, 2005
Is tailored therapy feasible in oncology?Giampietro Gasparini, Raffaele Longo, Francesco Torino, et al.
The International Journal of Biochemistry & Cell Biology|July 19, 2016
Management of non-small cell lung cancer in the era of personalized medicineGaetano Rocco, Alessandro Morabito, Alessandra Leone, et al.
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
The Lancet. Oncology|October 14, 2003
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?Giampietro Gasparini, Raffaele Longo, Roberta Sarmiento, et al.
Cancer Journal (Sudbury, Mass.)|August 2, 2005
Thalidomide is inactive in heavily pretreated patients with metastatic breast cancerAlessandro Morabito, Guido Carillio, Raffaele Longo, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Giuseppe Pompilio, Alessandro Morabito, Diego L Cortinovis, et al.
Nature Communications|March 27, 2025
Fatigue damage reduction in hydropower startups with machine learningTill Muser, Ekaterina Krymova, Alessandro Morabito, et al.
Cancers|April 30, 2021
Promising Role of Circulating Tumor Cells in the Management of SCLCAntonella De Luca, Marianna Gallo, Claudia Esposito, et al.
Cancers|July 27, 2024
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future ChallengesDiego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 3, 2005
A complete atrioventricular block secondary to myocardial metastases of lung cancer. A case reportDavid Mocini, Raffaele Longo, Furio Colivicchi, et al.
The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.
Critical Reviews in Oncology/Hematology|December 13, 2005
Is tailored therapy feasible in oncology?Giampietro Gasparini, Raffaele Longo, Francesco Torino, et al.
The International Journal of Biochemistry & Cell Biology|July 19, 2016
Management of non-small cell lung cancer in the era of personalized medicineGaetano Rocco, Alessandro Morabito, Alessandra Leone, et al.
Pageof 20